[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2015-2027 Global Epilepsy Therapeutics Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

April 2020 | 138 pages | ID: 2211F02B9A9BEN
Maia Research

US$ 3,460.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The worldwide market for Epilepsy Therapeutics is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
Shire
Sanofi S.A
GlaxoSmithKline plc
Johnson & Johnson
Novartis AG
Valeant Pharmaceuticals International
Abbott Laboratories
Cephalon, Inc
Pfizer
Sunovion Pharmaceuticals


Major Types Covered
Ketogenic diet
Anti-epileptic drugs
Vagus nerve stimulate
Brain surgery

Major Applications Covered
Hospital
Clinic
Others

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027
1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Epilepsy Therapeutics Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Epilepsy Therapeutics Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE EPILEPSY THERAPEUTICS MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL EPILEPSY THERAPEUTICS MARKET-SEGMENTATION BY TYPE

5.1 Ketogenic diet
5.2 Anti-epileptic drugs
5.3 Vagus nerve stimulate
5.4 Brain surgery

6 GLOBAL EPILEPSY THERAPEUTICS MARKET-SEGMENTATION BY APPLICATION

6.1 Hospital
6.2 Clinic
6.3 Others

7 GLOBAL EPILEPSY THERAPEUTICS MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 Shire
  8.1.1 Shire Profile
  8.1.2 Shire Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 Shire Product/Solution Launches and Enhancements Analysis
  8.1.4 Shire Business Overview/Recent Development/Acquisitions
8.2 Sanofi S.A
  8.2.1 Sanofi S.A Profile
  8.2.2 Sanofi S.A Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 Sanofi S.A Product/Solution Launches and Enhancements Analysis
  8.2.4 Sanofi S.A Business Overview/Recent Development/Acquisitions
8.3 GlaxoSmithKline plc
  8.3.1 GlaxoSmithKline plc Profile
  8.3.2 GlaxoSmithKline plc Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 GlaxoSmithKline plc Product/Solution Launches and Enhancements Analysis
  8.3.4 GlaxoSmithKline plc Business Overview/Recent Development/Acquisitions
8.4 Johnson & Johnson
  8.4.1 Johnson & Johnson Profile
  8.4.2 Johnson & Johnson Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 Johnson & Johnson Product/Solution Launches and Enhancements Analysis
  8.4.4 Johnson & Johnson Business Overview/Recent Development/Acquisitions
8.5 Novartis AG
  8.5.1 Novartis AG Profile
  8.5.2 Novartis AG Sales, Growth Rate and Global Market Share from 2015-2020
  8.5.3 Novartis AG Product/Solution Launches and Enhancements Analysis
  8.5.4 Novartis AG Business Overview/Recent Development/Acquisitions
8.6 Valeant Pharmaceuticals International
  8.6.1 Valeant Pharmaceuticals International Profile
  8.6.2 Valeant Pharmaceuticals International Sales, Growth Rate and Global Market Share from 2015-2020
  8.6.3 Valeant Pharmaceuticals International Product/Solution Launches and Enhancements Analysis
  8.6.4 Valeant Pharmaceuticals International Business Overview/Recent Development/Acquisitions
8.7 Abbott Laboratories
  8.7.1 Abbott Laboratories Profile
  8.7.2 Abbott Laboratories Sales, Growth Rate and Global Market Share from 2015-2020
  8.7.3 Abbott Laboratories Product/Solution Launches and Enhancements Analysis
  8.7.4 Abbott Laboratories Business Overview/Recent Development/Acquisitions
8.8 Cephalon, Inc
  8.8.1 Cephalon, Inc Profile
  8.8.2 Cephalon, Inc Sales, Growth Rate and Global Market Share from 2015-2020
  8.8.3 Cephalon, Inc Product/Solution Launches and Enhancements Analysis
  8.8.4 Cephalon, Inc Business Overview/Recent Development/Acquisitions
8.9 Pfizer
  8.9.1 Pfizer Profile
  8.9.2 Pfizer Sales, Growth Rate and Global Market Share from 2015-2020
  8.9.3 Pfizer Product/Solution Launches and Enhancements Analysis
  8.9.4 Pfizer Business Overview/Recent Development/Acquisitions
8.10 Sunovion Pharmaceuticals
  8.10.1 Sunovion Pharmaceuticals Profile
  8.10.2 Sunovion Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
  8.10.3 Sunovion Pharmaceuticals Product/Solution Launches and Enhancements Analysis
  8.10.4 Sunovion Pharmaceuticals Business Overview/Recent Development/Acquisitions

9 GLOBAL EPILEPSY THERAPEUTICS MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America Epilepsy Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Epilepsy Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Epilepsy Therapeutics Production Analysis from 2015-2020
10.4 North America Epilepsy Therapeutics Consumption Analysis from 2015-2020
10.5 North America Epilepsy Therapeutics Import and Export from 2015-2020
10.6 North America Epilepsy Therapeutics Value, Production and Market Share by Type (2015-2020)
10.7 North America Epilepsy Therapeutics Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Epilepsy Therapeutics by Country (United States, Canada)
  10.8.1 North America Epilepsy Therapeutics Sales by Country (2015-2020)
  10.8.2 North America Epilepsy Therapeutics Consumption Value by Country (2015-2020)
10.9 North America Epilepsy Therapeutics Market PEST Analysis

11 EUROPE

11.1 Europe Epilepsy Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Epilepsy Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Epilepsy Therapeutics Production Analysis from 2015-2020
11.4 Europe Epilepsy Therapeutics Consumption Analysis from 2015-2020
11.5 Europe Epilepsy Therapeutics Import and Export from 2015-2020
11.6 Europe Epilepsy Therapeutics Value, Production and Market Share by Type (2015-2020)
11.7 Europe Epilepsy Therapeutics Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Epilepsy Therapeutics by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe Epilepsy Therapeutics Sales by Country (2015-2020)
  11.8.2 Europe Epilepsy Therapeutics Consumption Value by Country (2015-2020)
11.9 Europe Epilepsy Therapeutics Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific Epilepsy Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Epilepsy Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Epilepsy Therapeutics Production Analysis from 2015-2020
12.4 Asia-Pacific Epilepsy Therapeutics Consumption Analysis from 2015-2020
12.5 Asia-Pacific Epilepsy Therapeutics Import and Export from 2015-2020
12.6 Asia-Pacific Epilepsy Therapeutics Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Epilepsy Therapeutics Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Epilepsy Therapeutics by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific Epilepsy Therapeutics Sales by Country (2015-2020)
  12.8.2 Asia-Pacific Epilepsy Therapeutics Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Epilepsy Therapeutics Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America Epilepsy Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Epilepsy Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Epilepsy Therapeutics Production Analysis from 2015-2020
13.4 Latin America Epilepsy Therapeutics Consumption Analysis from 2015-2020
13.5 Latin America Epilepsy Therapeutics Import and Export from 2015-2020
13.6 Latin America Epilepsy Therapeutics Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Epilepsy Therapeutics Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Epilepsy Therapeutics by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America Epilepsy Therapeutics Sales by Country (2015-2020)
  13.8.2 Latin America Epilepsy Therapeutics Consumption Value by Country (2015-2020)
13.9 Latin America Epilepsy Therapeutics Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa Epilepsy Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Epilepsy Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Epilepsy Therapeutics Production Analysis from 2015-2020
14.4 Middle East & Africa Epilepsy Therapeutics Consumption Analysis from 2015-2020
14.5 Middle East & Africa Epilepsy Therapeutics Import and Export from 2015-2020
14.6 Middle East & Africa Epilepsy Therapeutics Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Epilepsy Therapeutics Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Epilepsy Therapeutics by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa Epilepsy Therapeutics Sales by Country (2015-2020)
  14.8.2 Middle East & Africa Epilepsy Therapeutics Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Epilepsy Therapeutics Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL EPILEPSY THERAPEUTICS MARKET FROM 2020-2027

15.1 Future Forecast of the Global Epilepsy Therapeutics Market from 2020-2027 Segment by Region
15.2 Global Epilepsy Therapeutics Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Epilepsy Therapeutics Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source

LIST OF TABLES AND FIGURES

Global Epilepsy Therapeutics Market Value ($) and Growth Rate of Epilepsy Therapeutics from 2015-2027
Global Epilepsy Therapeutics Production and Growth Rate Segment by Product Type from 2015-2027
Global Epilepsy Therapeutics Consumption and Growth Rate Segment by Application from 2015-2027
Figure Epilepsy Therapeutics Picture
Table Product Specifications of Epilepsy Therapeutics
Table Driving Factors for this Market
Table Industry News of Epilepsy Therapeutics Market
Figure Value Chain Status of Epilepsy Therapeutics
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Epilepsy Therapeutics Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Epilepsy Therapeutics Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Ketogenic diet of Epilepsy Therapeutics
Figure Anti-epileptic drugs of Epilepsy Therapeutics
Figure Vagus nerve stimulate of Epilepsy Therapeutics
Figure Brain surgery of Epilepsy Therapeutics
Table Global Epilepsy Therapeutics Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Epilepsy Therapeutics Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Hospital of Epilepsy Therapeutics
Figure Clinic of Epilepsy Therapeutics
Figure Others of Epilepsy Therapeutics
Table Global Epilepsy Therapeutics Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Epilepsy Therapeutics Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Epilepsy Therapeutics
Figure Online Channel of Epilepsy Therapeutics
Table Shire Profile (Company Name, Plants Distribution, Sales Region)
Figure Shire Sales and Growth Rate from 2015-2020
Figure Shire Revenue ($) and Global Market Share from 2015-2020
Table Shire Epilepsy Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Sanofi S.A Profile (Company Name, Plants Distribution, Sales Region)
Figure Sanofi S.A Sales and Growth Rate from 2015-2020
Figure Sanofi S.A Revenue ($) and Global Market Share from 2015-2020
Table Sanofi S.A Epilepsy Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table GlaxoSmithKline plc Profile (Company Name, Plants Distribution, Sales Region)
Figure GlaxoSmithKline plc Sales and Growth Rate from 2015-2020
Figure GlaxoSmithKline plc Revenue ($) and Global Market Share from 2015-2020
Table GlaxoSmithKline plc Epilepsy Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Johnson & Johnson Profile (Company Name, Plants Distribution, Sales Region)
Figure Johnson & Johnson Sales and Growth Rate from 2015-2020
Figure Johnson & Johnson Revenue ($) and Global Market Share from 2015-2020
Table Johnson & Johnson Epilepsy Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Novartis AG Profile (Company Name, Plants Distribution, Sales Region)
Figure Novartis AG Sales and Growth Rate from 2015-2020
Figure Novartis AG Revenue ($) and Global Market Share from 2015-2020
Table Novartis AG Epilepsy Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Valeant Pharmaceuticals International Profile (Company Name, Plants Distribution, Sales Region)
Figure Valeant Pharmaceuticals International Sales and Growth Rate from 2015-2020
Figure Valeant Pharmaceuticals International Revenue ($) and Global Market Share from 2015-2020
Table Valeant Pharmaceuticals International Epilepsy Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Abbott Laboratories Profile (Company Name, Plants Distribution, Sales Region)
Figure Abbott Laboratories Sales and Growth Rate from 2015-2020
Figure Abbott Laboratories Revenue ($) and Global Market Share from 2015-2020
Table Abbott Laboratories Epilepsy Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Cephalon, Inc Profile (Company Name, Plants Distribution, Sales Region)
Figure Cephalon, Inc Sales and Growth Rate from 2015-2020
Figure Cephalon, Inc Revenue ($) and Global Market Share from 2015-2020
Table Cephalon, Inc Epilepsy Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Pfizer Profile (Company Name, Plants Distribution, Sales Region)
Figure Pfizer Sales and Growth Rate from 2015-2020
Figure Pfizer Revenue ($) and Global Market Share from 2015-2020
Table Pfizer Epilepsy Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Sunovion Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Sunovion Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Sunovion Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Sunovion Pharmaceuticals Epilepsy Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Epilepsy Therapeutics Production Value ($) by Region from 2015-2020
Table Global Epilepsy Therapeutics Production Value Share by Region from 2015-2020
Table Global Epilepsy Therapeutics Production by Region from 2015-2020
Table Global Epilepsy Therapeutics Consumption Value ($) by Region from 2015-2020
Table Global Epilepsy Therapeutics Consumption by Region from 2015-2020
Table North America Epilepsy Therapeutics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Epilepsy Therapeutics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Epilepsy Therapeutics Import and Export from 2015-2020
Table North America Epilepsy Therapeutics Value ($) by Type (2015-2020)
Table North America Epilepsy Therapeutics Production by Type (2015-2020)
Table North America Epilepsy Therapeutics Consumption by Application (2015-2020)
Table North America Epilepsy Therapeutics Consumption by Country (2015-2020)
Table North America Epilepsy Therapeutics Consumption Value ($) by Country (2015-2020)
Figure North America Epilepsy Therapeutics Market PEST Analysis
Table Europe Epilepsy Therapeutics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Epilepsy Therapeutics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Epilepsy Therapeutics Import and Export from 2015-2020
Table Europe Epilepsy Therapeutics Value ($) by Type (2015-2020)
Table Europe Epilepsy Therapeutics Production by Type (2015-2020)
Table Europe Epilepsy Therapeutics Consumption by Application (2015-2020)
Table Europe Epilepsy Therapeutics Consumption by Country (2015-2020)
Table Europe Epilepsy Therapeutics Consumption Value ($) by Country (2015-2020)
Figure Europe Epilepsy Therapeutics Market PEST Analysis
Table Asia-Pacific Epilepsy Therapeutics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Epilepsy Therapeutics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Epilepsy Therapeutics Import and Export from 2015-2020
Table Asia-Pacific Epilepsy Therapeutics Value ($) by Type (2015-2020)
Table Asia-Pacific Epilepsy Therapeutics Production by Type (2015-2020)
Table Asia-Pacific Epilepsy Therapeutics Consumption by Application (2015-2020)
Table Asia-Pacific Epilepsy Therapeutics Consumption by Country (2015-2020)
Table Asia-Pacific Epilepsy Therapeutics Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Epilepsy Therapeutics Market PEST Analysis
Table Latin America Epilepsy Therapeutics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Epilepsy Therapeutics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Epilepsy Therapeutics Import and Export from 2015-2020
Table Latin America Epilepsy Therapeutics Value ($) by Type (2015-2020)
Table Latin America Epilepsy Therapeutics Production by Type (2015-2020)
Table Latin America Epilepsy Therapeutics Consumption by Application (2015-2020)
Table Latin America Epilepsy Therapeutics Consumption by Country (2015-2020)
Table Latin America Epilepsy Therapeutics Consumption Value ($) by Country (2015-2020)
Figure Latin America Epilepsy Therapeutics Market PEST Analysis
Table Middle East & Africa Epilepsy Therapeutics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Epilepsy Therapeutics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Epilepsy Therapeutics Import and Export from 2015-2020
Table Middle East & Africa Epilepsy Therapeutics Value ($) by Type (2015-2020)
Table Middle East & Africa Epilepsy Therapeutics Production by Type (2015-2020)
Table Middle East & Africa Epilepsy Therapeutics Consumption by Application (2015-2020)
Table Middle East & Africa Epilepsy Therapeutics Consumption by Country (2015-2020)
Table Middle East & Africa Epilepsy Therapeutics Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Epilepsy Therapeutics Market PEST Analysis
Table Global Epilepsy Therapeutics Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Epilepsy Therapeutics Production and Growth Rate Forecast by Region (2020-2027)
Table Global Epilepsy Therapeutics Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Epilepsy Therapeutics Production and Growth Rate Forecast by Type (2020-2027)
Table Global Epilepsy Therapeutics Consumption and Growth Rate Forecast by Application (2020-2027)


More Publications